DEERFIELD, Ill. — Walgreens Boots Alliance Inc. shareholders have approved the acquisition of the company by Sycamore Partners Management.
According to preliminary results, 96% of votes cast by shareholders at a special meeting were in favor of the deal. In addition, 95% of unaffiliated shareholders backed the deal.
“We appreciate the consideration and overwhelming support from our shareholders in our value-maximizing transaction with Sycamore,” said WBA CEO Tim Wentworth. “With Sycamore’s partnership, we will be better positioned to accelerate our turnaround strategy, further enhance the customer, patient and team member experience and become the first choice for pharmacy, retail and health services. We look forward to closing the transaction and entering this next chapter.”
As announced on March 6, WBA shareholders will receive $11.45 per share in cash at closing, and one non-transferable Divested Asset Proceeds right to receive up to an additional $3.00 in cash per share from the future monetization of WBA’s debt and equity interests in VillageMD, which includes the Village Medical, Summit Health and CityMD businesses.
WBA expects to close the deal in the third or fourth quarter of 2025, subject to customary closing conditions, including the receipt of required regulatory approvals.
The final voting results of the special meeting will be reported in a Form 8-K filed by WBA with the Securities and Exchange Commission.
